Diametric Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-8,589
| Closed | -$964K | – | 214 |
|
|
2020
Q2 | $964K | Buy |
+8,589
| New | +$964K | 0.74% | 53 |
|
|
2019
Q3 | – | Sell |
-25,651
| Closed | -$3.36M | – | 154 |
|
|
2019
Q2 | $3.36M | Buy |
+25,651
| New | +$3.36M | 2.13% | 11 |
|
|
2018
Q3 | – | Sell |
-11,669
| Closed | -$1.45M | – | 130 |
|
|
2018
Q2 | $1.45M | Sell |
11,669
-1,735
| -13% | -$215K | 1.36% | 34 |
|
|
2018
Q1 | $1.49M | Sell |
13,404
-2,341
| -15% | -$261K | 1.13% | 35 |
|
|
2017
Q4 | $1.88M | Buy |
+15,745
| New | +$1.88M | 1.14% | 37 |
|